Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $2.0 billion.

  • Fresenius Medical Care AG's Cash & Current Investments rose 3611.1% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 3611.1%. This contributed to the annual value of $1.7 billion for FY2024, which is 2320.6% up from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Cash & Current Investments of $2.0 billion as of Q3 2025, which was up 3611.1% from $1.9 billion recorded in Q2 2025.
  • Fresenius Medical Care AG's Cash & Current Investments' 5-year high stood at $2.0 billion during Q3 2025, with a 5-year trough of $1.2 billion in Q3 2021.
  • Over the past 5 years, Fresenius Medical Care AG's median Cash & Current Investments value was $1.5 billion (recorded in 2024), while the average stood at $1.5 billion.
  • In the last 5 years, Fresenius Medical Care AG's Cash & Current Investments soared by 4457.96% in 2021 and then crashed by 1839.44% in 2023.
  • Over the past 5 years, Fresenius Medical Care AG's Cash & Current Investments (Quarter) stood at $1.7 billion in 2021, then fell by 8.62% to $1.6 billion in 2022, then decreased by 9.84% to $1.4 billion in 2023, then rose by 23.21% to $1.7 billion in 2024, then increased by 18.1% to $2.0 billion in 2025.
  • Its Cash & Current Investments stands at $2.0 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $1.7 billion for Q1 2025.